Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifier

Affiliations

• ¹ Department of Microbiology and Immunology, University of British Columbia, 2125 East Mall, Vancouver, BC, Canada.
• ² Terry Fox Laboratory, BC Cancer Research Institute, Vancouver, BC, Canada.
• ³ Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
• ⁴ Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, NC, USA.
• ⁵ Department of Molecular Biology and Biochemistry, Faculty of Science, Simon Fraser University, Burnaby, BC, Canada.
• ⁶ Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA.
• ⁷ Howard Hughes Medical Institute, University of Texas Health San Antonio, San Antonio, TX, USA.
• ⁸ IUCT-Oncopole Toulouse, Toulouse, France.
• ⁹ Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
• ¹⁰ Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver General Hospital, BC Cancer, Vancouver, BC, Canada.
• ¹¹ Terry Fox Laboratory, BC Cancer Research Institute, Vancouver, BC, Canada. [email protected].
• ¹² Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver General Hospital, BC Cancer, Vancouver, BC, Canada. [email protected].